See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420720_2023_iBio_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 18, '00201 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss CALC2': 3}} |
Graph
Absolute values for 0001420720, iBio Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,070,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,851,000 |
| 2 | PropertyPlantAndEquipmentNet | 36,661,000 |
| 3 | remainder_Assets | 12,824,000 |
| 4 | LiabilitiesCurrent | 30,436,000 |
| 5 | LiabilitiesNoncurrent | 5,455,000 |
| 6 | remainder_Liabilities | 30,000 |
| 7 | CostOfGoodsAndServicesSold | 216,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,128,000 |
| 9 | ResearchAndDevelopmentExpense | 17,729,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,383,000 |
| 12 | remainder_NetIncome | -614,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 99,406,000 |
| 1 | Liabilities | 35,921,000 |
| 2 | Expenses | 52,073,000 |
| 3 | Revenues | 2,383,000 |
| 4 | StockholdersEquity | 63,485,000 |
| 5 | NetIncome | -50,304,000 |
| 6 | ComprehensiveNetIncome | -50,304,000 |
| 7 | BaseVar | 95,198,500 |
| 8 | EconomicCapitalRatio | 0.870 |
Edgar->Model Mapping
Feature Distribution
Change over Time
